Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Johnson

Showing results (321-330 of 376) with videos related to

Pageof 38
Sort By:
Blood|April 1, 1985
Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observationsD H Johnson, R Linde, J D Hainsworth, et al.
Cancer|December 18, 2001
Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma C J Sweeney, J Zhu, A B Sandler, et al.
Cancer Research|September 15, 1989
Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641)J D Hainsworth, K R Hande, W G Satterlee, et al.
Clinical Lung Cancer|January 17, 2004
A phase I trial of outpatient weekly docetaxel and concurrent radiation therapy for stage III unresectable non small-cell lung cancer: a Vanderbilt Cancer Center Affiliate Network (VCCAN) TrialH Choy, R F DeVore, K R Hande, et al.
Alimentary Pharmacology & Therapeutics|May 1, 2014
Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitisD H Johnson, S Khanna, T C Smyrk, et al.
The New England Journal of Medicine|November 9, 2000
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology GroupS M Keller, S Adak, H Wagner, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2001
Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trialH Choy, R F DeVore, K R Hande, et al.
British Journal of Cancer|April 5, 2007
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serumS A Belinsky, M J Grimes, E Casas, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2006
Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experienceI Gauthier, K Ding, T Winton, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trailB D Wamil, G B Thurman, H W Sundell, et al.
Pageof 38

Showing results (321-330 of 376) with videos related to

Sort By:
Pageof 38
Blood|April 1, 1985
Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observationsD H Johnson, R Linde, J D Hainsworth, et al.
Cancer|December 18, 2001
Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma C J Sweeney, J Zhu, A B Sandler, et al.
Cancer Research|September 15, 1989
Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641)J D Hainsworth, K R Hande, W G Satterlee, et al.
Clinical Lung Cancer|January 17, 2004
A phase I trial of outpatient weekly docetaxel and concurrent radiation therapy for stage III unresectable non small-cell lung cancer: a Vanderbilt Cancer Center Affiliate Network (VCCAN) TrialH Choy, R F DeVore, K R Hande, et al.
Alimentary Pharmacology & Therapeutics|May 1, 2014
Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitisD H Johnson, S Khanna, T C Smyrk, et al.
The New England Journal of Medicine|November 9, 2000
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology GroupS M Keller, S Adak, H Wagner, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2001
Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trialH Choy, R F DeVore, K R Hande, et al.
British Journal of Cancer|April 5, 2007
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serumS A Belinsky, M J Grimes, E Casas, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2006
Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experienceI Gauthier, K Ding, T Winton, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trailB D Wamil, G B Thurman, H W Sundell, et al.
Pageof 38